首页> 中文期刊> 《世界核心医学期刊文摘:胃肠病学分册》 >肝细胞肝癌患者肝脏内CD4^+ CD25^+调节性T细胞水平增加

肝细胞肝癌患者肝脏内CD4^+ CD25^+调节性T细胞水平增加

         

摘要

Background/Aims:The immune response to tumor-specific antigens is typically unable to control the growth and spread of malignant cells.Accumulating evidence indicates that the suppressive effects of CD4+ CD25+ regulatory T-cells are at least partially responsible for the failure of immune-mediated elimination of tumor cells.Methods:We have studied 25 patients with hepatocellular carcinoma(HCC) .The liver tissues with HCC were separated into the marginal region of tumor(peri-tumor region) and the non-tumor region distant from the tumor.CD4+ CD25+ T-cells were quantified in the blood and the liver by flow cytometry and immunohistochemistry,and their effect on T-cell proliferation and activation was determined.Results:We found a significant increase in both the proportion and absolute numbers of CD4+ CD25+ T-cells in the peri-tumor regions,but not in unaffected areas(9.5 ± 4.5 vs.4.6 ± 2.8%,P = 0.011) .CD4+ CD25+ T-cells isolated from peri-tumor regions displayed phenotype markers characteristic of regulatory T-cells,and expressed Foxp3 mRNA.CD8+ T-cells in peri-tumor regions were inversely proportional to CD4+ CD25+ T-cells in the same region(P < 0.001) .Moreover,isolated CD4+ CD25+ T-cells inhibited autologous CD8+ T-cell proliferation.Conclusions:Our results suggest that CD4+ CD25+ T-cells in the marginal region of HCC may play a critical role in controlling CD8+ cytotoxic T-cell activity and,thereby,contribute to the progression of HCC.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号